Innovatus to provide up to $42 mln to Personal Genome Diagnostics

Innovatus Capital Partners LLC has agreed to provide up to $42 million to Personal Genome Diagnostics Inc. Based in Baltimore, Personal Genome Diagnostics Inc is a developer of tissue-based and liquid biopsy technologies for cancer genomics.

4 October 2018•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles